Rheumatologic diseases like systemic lupus erythematosus (SLE), ankylosing spondylitis, and rheumatoid arthritis can present significant challenges for biopharma. These conditions are chronic, complex, and multisystemic. While traditional clinical trials provide essential insights, they often fail to capture the full spectrum of patient experiences or reflect the diversity seen in real-world populations. Real-world data (RWD), combined[…]

By Vadim Pinsky, PhD, and Gabe Goldfeder, M.A. One of the key frameworks for understanding data analytics in Real-World Evidence (RWE) is the “Five Vs”: Velocity, Volume, Variety, Veracity, and Value. Each aspect plays a crucial role in the data collection and analysis process, shaping how efficiently and accurately insights are generated. For healthcare professionals,[…]

Understanding the patient journey has become crucial for improving treatment outcomes and addressing unmet needs. Pharmaceutical companies need deeper insights into the patient experience — from initial symptoms through diagnosis, treatment, and long-term management – to improve market visibility and marketing opportunities, demonstrate the value of treatments and treatment effectiveness, and ensure the right patients[…]

By Richard Gliklich, MD, CEO, OM1  |   May 22, 2023 Integrated evidence generation (IEG) is a framework for generating evidence to support decision-making in healthcare. It involves the integration of multiple sources of real-world data (RWD), including electronic health records (EHR), claims data, and patient-generated data, to provide a more comprehensive and accurate view of[…]